NIPC Law

Author  Thirunavukkarasye-Raveendran   Licence CC BY- 4.0 Deed   Source Wikimedia Commons   Jane Lambert Patents Court (Mr Justice Mellor)  Abbott Diabetes Care Inc and others v Dexcom Incorporated and others   [2024] EWHC 36 (Pat) This was the first of three trials between Abbott Diabetes Care Inc. and its subsidiaries ("Abbott") and Dexcom Incorporated and its subsidiaries ("Dexcom") over patents owned by those companies in the field of continuous glucose monitoring ("CGM").  Abbott sued Dexcom for infringing  EP (UK) 2 146 627 ("EP627") entitled "Method and Apparatus for Providing Data Processing and Control in Medical Communication System"  and  EP (UK) 2 476 223 ("EP223") entitled "Methods and Articles of Manufacture for Hosting a Safety Critical Application on an Uncontrolled Data Processing Device ". Dexcom counterclaimed for revocation of both patents on grounds of lack of novelty  and inventive step and in...

Jane Lambert   Patents Court (Mr Justice Richards)  Abbott Diabetes Care Inc and others v Dexcom Inc and others [2023] EWHC 2591 (Ch) (18 Oct 2023) This was a claim by Abbot Daiabetes Care Inc and others ("Abbott") for infringement of European patent (UK)  2549918B1 for Medical device inserters and processes of inserting and using medical devices  and a counterclaim by Dexcom Inc and others ("Dexcom") for revocation of the patent on grounds of added matter , anticipation . insufficiency  and obviousness ,  According to Mr Justice Richatrds who tried the action and counterclaim on 6 and 7 July 2023, this was the third of a series of UK patent infringement/validity trials concerning continuous glucose monitoring ("CGM") systems .  Abbott indicated that it would apply to amend the patent if the court found it invalid.  By para [208] of his judgment which he handed down on 18 Oct 2023 the judge dismissed the claim and by [209] he dismissed the counte...